A Clear Guide to Understanding Your Report - Most of us are familiar with routine sugar checks that show fasting or post-meal ...

Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...

Metformin failed to prevent metabolic syndrome in men on hormonal therapy for prostate cancer but did improve risk factors ...

If you have type 2 diabetes, your doctor may suggest different ways to keep your blood sugar in a healthy range. Here's why ...

Poor blood sugar control in adolescence increases likelihood for developing neuropathy in adulthood. (HealthDay News) — Poor blood sugar control in adolescents with type 1 diabetes (T1D) increases the ...

Monica Barfield, DNP, APRN, AGACNP-BC, FNP-BC, owns New Horizon Primary Care and serves as Region One director for the ...

Explore the benefits of exercise for kidney disease and type 2 diabetes, plus its challenges and how to incorporate physical ...

An experimental GLP-1/glucagon (GCP) dual receptor agonist from Eli Lilly and its Chinese partner Innovent has bested Novo Nordisk’s reigning GLP-1 semaglutide in a phase 3 study across both b | ...

Topline data were announced from two phase 3 trials evaluating orforglipron, an oral GLP-1 receptor agonist, in patients with type 2 diabetes.

Patients with Type 1 diabetes are often excluded from diabetes and weight loss trials. Forty years ago, the vast majority of patients with Type 1 diabetes didn’t need help with the problem of being ...

Every time we eat, glucose levels will be affected. Fortunately, these smart dietary strategies will you help reduce your ...

Learn what really happens to your blood sugar when you add artificial sweeteners to your diet. Discover how they compare to sugar, their effects on insulin and gut health, and what research says about ...